Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ABVC lets get back into those 2s
BTTX Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease
BETS and ROI moving pre-market
KTRA what a drop - back to 33-34 zone?
MBOT watching for 2 break
MBOT - Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met
LAES - possible 5 today? (OS is only 7.5M)
SNES moving AH
Gap to close at around 3.5 - maybe tomorrow ?
RMCO - maybe linked to this news ~ float is extremely low 0.74M
Royalty Management Holding Corporation’s and American Resources Corporation’s Investment In Advanced Magnetic Labs, Inc. Results in Commercial Manufacturing of Permanent Magnets
Tuesday, 19 December 2023 08:30
our CEO purchased another 25k of shares
Looks like second leg is starting
10 is coming today?
A close at 5 is great - but the best is yet to come
What would be a fair value? Thx
News: Borqs’ Subsidiary, Holu Hou Energy, Receives Multiple Orders for HoluPower xP Solar Energy Storage Systems in California, the Largest USA Market
just broke 0.01
what's going on? any news?
Watch for 2 dollar breakout today
nice close - in at 0.29 today , 3448 shares
short squeeze ongoing?
we need a bit more volume , but nice to see a breakout
Therapeutic Solutions International Spin-Off Company Campbell Neurosciences Announces Successful Preclinical Studies of CampbellCell for Treatment of Bipolar Disorder
Validation of Efficacy for Second Suicide-Associated Psychiatric Indication Supports Push for Clinical Entry of Novel Brain-Healing Stem Cell Type
ELK CITY, Idaho--(BUSINESS WIRE)-- Therapeutic Solutions International announced positive data and filing of a patent covering the use of CampbellCell for treatment of Bipolar Disorder by the Company’s suicide prevention based spin-off Campbell Neurosciences.
In a series of animal experiments using an established animal model of bipolar disorder, superior inhibition of behavioral abnormality as measured in the “Open Field Test”, as well as reduction in brain inflammation was observed in animals treated with CampbellCell as compared to control stem cells. Furthermore, it was found that protection from behavioral abnormalities could be transferred to naïve mice by T cell infusions, indicating that an immunological effect was present.
“We initially demonstrated a biological basis to suicidality by our clinical trial demonstrating validity of the Campbell Score1,2. We subsequently demonstrated that the CampbellCell, which possesses potent regenerative and anti-inflammatory activities is capable of treating Schizophrenia in animal models3. Today we disclosed that the CampbellCell is also capable of treating bipolar disorder models,” said Kalina O’Connor, President, and CEO of Campbell Neurosciences. “We are advancing toward clinical trials in both Schizophrenia and Bipolar Disorder, which we believe will position the Company as the first to merge psychiatry with regenerative medicine.”
“Having used various stem cell therapies in my practice, including JadiCell, for which we are currently running a Phase III clinical trial, I have seen the potent effects this regenerative approach can have on many branches of medicine,” said Dr. James Veltmeyer, Chief Medical Officer of the Company, and co-inventor of the patent. “I am proud to be working with Ms. O’Connor and her team at Campbell Neurosciences in creating, what I believe to be, the first science-based approach to diagnosing and treating suicide as a disease and not a choice.”
Bipolar Disorder and Schizophrenia are recognized as major contributors to suicide and have been associated with various immunological abnormalities. For a review of the inflammatory nature of suicide-associated mental illness, the reader is referred to a paper published by Ms. O’Conner4.
“Campbell Neurosciences was capable of successfully raising capital, running two clinical trials for its diagnostic platform, and now has late preclinical data on two significant suicide-associated indications. This speaks volumes for our model of incubating technologies and spinning them off,” said Timothy Dixon, President, and CEO of Therapeutic Solutions International and co-inventor. “Through cross-fertilizing and sharing resources and talent between our companies, I am excited to see acceleration in clinical development and hopefully new treatments for this immensely important and underserved area of mental health.”
Falling sharply (from 4.5 to 3) ....where's the bottom ?
0.75 break and it flies
Nice reversal ongoing on 5 min chart
Already nice volume pre-market
Looks like we're on fire today
indeed building nicely - now we need some volume
bounce coming?
Thanks for the insights - will keep a close eye on TMNA
Followed you on BDCO, in at 1.45 - but i dont follow you blindly
The answer is here: https://www.otcmarkets.com/stock/TMNA/security
what's your opinion about the share structure? AS is quite high.
nice rebound today - hope we're above 1 dollar pretty soon
Nice move the last few days